Oxford Interrupts Trial of AstraZeneca COVID Vaccine in Children and Adolescents for Blood Coagulation
Study shows that a single dose of AstraZeneca or Pfizer COVID-19 vaccine reduces the risk of hospitalization by more than 80%
The UK becomes the first country to launch the AstraZeneca-Oxford vaccine as closures will be imminent
